Navigation Links
SynCare Announces Ian Duncan Joins Board of Directors
Date:12/17/2008

INDIANAPOLIS, Dec. 17 /PRNewswire/ -- SynCare, LLC, today announced that Ian Duncan has joined the Board of Directors. Mr. Duncan, a world-renowned author and expert in the field of disease management and the economics of chronic care, brings a wealth of experience and knowledge to the SynCare board of directors.

"I am delighted that Ian Duncan has joined our team," commented Stephanie DeKemper, Vice Chairman and Interim CEO. "Ian is a pioneer in the use of risk-adjustment and predictive modeling techniques for achieving improved outcomes in the health care arena. In his role, we see perfect synergy in tying his experience and contributions with the goals, objectives and capabilities of SynCare."

Ian Duncan is founder and president of Solucia, Inc., a provider of actuarial and consulting services to the healthcare financing industry. Solucia focuses on medical management, predictive modeling and outcomes services to health insurers, employers and state Medicaid plans. Mr. Duncan has 30 years of experience in healthcare and insurance product design, management, financing, pricing and delivery. He is active in public policy and healthcare reform, having twice won the Disease Management Association of America's prize for the best published paper on disease management. In addition to numerous awards, he is a frequent speaker at industry events.

Mr. Duncan's recent groundbreaking book, Managing and Evaluating Healthcare Intervention Programs, represents essential reading for healthcare professionals committed to driving return on investment in care management efforts. "This book provides a usable blueprint for the financial management and evaluation of healthcare intervention programs," notes Duncan.

ABOUT SYNCARE LLC

SynCare, LLC is an innovator in disease and case management, with discrete expertise in managing asthma, diabetes, prenatal, obesity, and other chronic co-morbid conditions. SynCare's flexible and scalable services are designed to create behavioral changes that improve clinical outcomes, such as improved quality of life, increased employee productivity, and reduced workplace absenteeism. Headquartered in Indianapolis, Ind., SynCare, LLC is a privately held corporation. SynCare is certified as a Minority Business Enterprise (MBE) and as a Veteran Owned Small Business (VOSB). To learn more about the company, please visit www.SynCareLLC.com or call (317) 755-4017.

    Contact: 2.0 Group
    Kelly Smith
    kelly@2-0group.com
    317-577-1804


'/>"/>
SOURCE SynCare, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. SynCare Pioneers New Approach to Lower Healthcare Costs
2. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
3. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
4. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
5. HEI, Inc. Announces Sale of RFID Division Assets
6. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
7. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
8. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
9. Brooke Franchise Corporation Announces Selected July Results
10. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
11. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/26/2017)... ... July 26, 2017 , ... Team Type 1 Foundation, ... medicine for everyone affected by diabetes, is excited to announce the 106 college athletes ... Program. , Established in 2005, the Team Type 1 Foundation has bestowed a ...
(Date:7/26/2017)... BC (PRWEB) , ... July 26, 2017 , ... ... (the “Company” or “Isodiol”) a global cannabis innovator, specializing in the development of ... the period from April 1, 2017 to June 30, 2017. Iso International LLC ...
(Date:7/26/2017)... ... July 26, 2017 , ... The number of adults 65 years or ... ways to improve asthma control in the population are not well described. In a ... Practice), an official journal of the American Academy of Allergy, Asthma & Immunology (AAAAI), ...
(Date:7/25/2017)... MOORE, OK (PRWEB) , ... July 25, 2017 ... ... are proud to announce the launch of their partnership to provide the ... is the first pharmacy-focused platform in the country with the ability to develop ...
(Date:7/25/2017)... ... July 25, 2017 , ... ... provider in the United States, today announced its partnership with financial technology company, ... , The foundation of the solution lies within Hyosung’s superior ATMs, assisted self-service ...
Breaking Medicine News(10 mins):
(Date:7/21/2017)... July 21, 2017  Endo International plc (NASDAQ: ... comprehensive review of its manufacturing network, the Company will ... facilities in Huntsville, Alabama . The ... over the next 12 to 18 months. The ... declining volumes of commoditized products and these restructuring actions ...
(Date:7/15/2017)... PHILADELPHIA , July 15, 2017 Enterin Inc., ... compounds to treat Parkinson,s disease (PD), today announced the completion ... included new investors New Ventures III, as well as the ... "We are absolutely thrilled to have the support of New ... of our investors as validation of the potential of our ...
(Date:7/13/2017)... 2017  New York City-based market research firm Kalorama Information ... aware of.  From new products to new costs, to the ... recently completed study, Potential Pipeline Disruptors . ... 1.  Age-Driven Growth - True Impact Moment Arriving ... the impact the growing population and, to a more extreme ...
Breaking Medicine Technology: